Our friends at the C-Path Institute have blazed that trail of personalized drug safety. Go to the C-Path website..it is full of initiatives and partnerships with the FDA. Ditto the folks at BG Medicine who have a CRADA with the FDA on a liver tox biomarker. Then there is the work of Dr. Ruano (that I have benefitted from directly -- put that in there because I know my critics just hate when I use personal examples ) with regard to side effects from statins at Genomas.
As Ray Woosley of C-Path asks about Personalized Medicine. When? Why Not Now? http://www.cpath-institute.orghttp://www.bgmedicine.comhttp://www.genomas.net